Arcturus Therapeutics (ARCT) Tops Q1 EPS by 17c
Tweet
Share
E-mailGet Alerts ARCT Hot Sheet
Join SI Premium – FREE
Arcturus Therapeutics (NASDAQ: ARCT) reported Q1 EPS of ($0.95), $0.17 better than the analyst estimate of ($1.12). Revenue for the quarter came in at $2.06 million.
For earnings history and earnings-related data on Arcturus Therapeutics (ARCT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral
- RBC Capital Starts Spartan Delta Corp (SDE:CN) (DALXF) at Outperform
- TUI AG (TUI1:GR) (TUIFY) PT Lowered to EUR10.10 at Deutsche Bank
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
